what is the best glp-1 med for weight loss Researchers move closer to matching patients with drug that works them Rx Trends: Real-World Data on
Description
Key Concepts What is GLP-1 (Glucagon-like Peptide-1)

While this risk has not been confirmed in human epidemiological studies, patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use orforglipron or any GLP-1 receptor agonist

Key Takeaways In 2024, the GLP-1 receptor agonist market generated revenue of US$ 53.5 billion , supported by a CAGR of 17.5% , and the market is projected to attain US$ 268.4 billion by 2033

Nat Rev Endocrinol (2020) 16(3):13546

[DOI] [PubMed] [Google Scholar] 276.Mace O.J., Schindler M., Patel S
